Unique ID issued by UMIN | UMIN000033125 |
---|---|
Receipt number | R000037738 |
Scientific Title | A randomized phase II study to evaluate the prolonged home enteral nutrition for patients after curative esophagectomy |
Date of disclosure of the study information | 2018/06/25 |
Last modified on | 2024/07/06 20:46:02 |
A randomized phase II study to evaluate the prolonged home enteral nutrition for patients after curative esophagectomy
Prolonged HEN
A randomized phase II study to evaluate the prolonged home enteral nutrition for patients after curative esophagectomy
Prolonged HEN
Japan |
Esophageal cancer
Gastrointestinal surgery |
Malignancy
NO
To examine the superiority of prolonged home enteral nutrition after curative esophagectomy.
Efficacy
Exploratory
Pragmatic
Phase II
Weight loss of more than 10% (24 weeks after surgery)
1) Change rate of QOL score, 2) Readmission rate, 3) Incidence of an adverse event (associated with home enteral nutrition), 4) Length of indwelling a feeding jejunostomy tube, 5) Adherence rate of protocol treatment
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Medicine |
Supplemental home enteral nutrition (at least 300 kcal / day or more) is continued up to 8 weeks after curative esophagectomy,
Supplemental home enteral nutrition (at least 300 kcal / day or more) is continued up to 24 weeks after curative esophagectomy,
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Primary lesions are all confined within the thoracic esophagus, 2) an esophageal epithelial malignancy, 3) Surgery approached from the neck, chest and abdomen, 4) R0 resection with D2 dissection, 5) Tube jejunostomy was constructed at the esophagectomy, 6) >20 and <80 y.o., 7) ECOG-PS 0 or 1, 8) No history of surgery for esophageal cancer, 9 ) No history of chemotherapy or radiotherapy, 10) a) WBC >2000 and <10000/mm3, b) PLT >50000/mm3, c) AST <100 IU/L, ALT <100IU/L, d) T-Bil <2.0 g/dl, e) Cre <1.5mg/dl, 11) Written consent
1) BMI <17.0 or >30.0, 2) Excision of other organs excluding stomach or gall bladder, 3) Active double cancer, 4) Pregnancy or breast-feeding, 5) Psychosis or mental symptoms, 6) Systemic administration of steroids, 7) History of myocardial infarction or unstable angina, 8) Poorly controlled hypertension, 9) Poorly controlled diabetes, 10) Respiratory disease requiring sustained oxygen therapy.
80
1st name | Takashi |
Middle name | |
Last name | Kamei |
Tohoku University Hospital
Department of Surgery
980-8574
1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, JAPAN
022-717-7214
tkamei@med.tohoku.ac.jp
1st name | Hiroshi |
Middle name | |
Last name | Okamoto |
Tohoku University Hospital
Department of Surgery
980-8574
1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, JAPAN
022-717-7214
hi-ok@surg.med.tohoku.ac.jp
Tohoku University Hospital
University grants of Tohoku University Hospital
Self funding
Institutional Review Board, Tohoku University Graduate School of Medicine
2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, JAPAN
022-717-8007
med-kenkyo@grp.tohoku.ac.jp
NO
東北大学病院(宮城県)
2018 | Year | 06 | Month | 25 | Day |
Unpublished
Terminated
2018 | Year | 06 | Month | 25 | Day |
2018 | Year | 06 | Month | 22 | Day |
2018 | Year | 07 | Month | 01 | Day |
2021 | Year | 05 | Month | 31 | Day |
2018 | Year | 06 | Month | 24 | Day |
2024 | Year | 07 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037738